Sanctions Screening in International Collaborations

Introduction

Sanctions screening in international collaborations is the process of checking whether foreign research institutions, universities, biotechnology companies, funders, suppliers, or individual researchers are subject to economic sanctions, trade restrictions, or export-control limitations before entering into or continuing a cross-border partnership.

International biotechnology collaborations may involve joint research, clinical trials, transfer of biological samples, genetic data sharing, laboratory equipment, technical assistance, and research funding. If a partner is sanctioned or linked to a prohibited end user, these activities may create legal exposure.

Sanctions screening is not a universal prohibition on working with every listed party. The legal consequences depend on the relevant sanctions regime, the nature of the transaction, the parties involved, and whether a licence or exception applies. Screening must therefore be combined with legal review, export-control classification, and end-use verification.

Case Laws and Enforcement Examples

*1. Indiana University — BIS Settlement (2024)

The U.S. Bureau of Industry and Security settled allegations involving 42 unlicensed exports of genetically modified fruit flies containing a controlled toxin subunit to research institutions and universities worldwide. The university voluntarily disclosed the conduct, cooperated with the investigation, and undertook remedial measures. The settlement included a suspended denial order and export-control training.

BIS Media+1

This enforcement action demonstrates that international research collaboration does not automatically exempt biological materials from export controls. It is an administrative settlement, not a judicial decision establishing a general sanctions-screening rule.

*2. Princeton University — BIS Enforcement (2021)

Princeton University faced export-control enforcement concerning biological materials transferred to overseas research institutions. The matter illustrates that universities must consider the controlled nature of research materials and licensing requirements before international transfers. This is an enforcement example rather than a court precedent.

bis.doc.gov

3. Institutional screening guidance

University research-security guidance commonly requires screening of international collaborators and institutions before engagement, and escalation of potential matches for expert review. For example, George Washington University identifies research collaborators, sponsors, academic partners, vendors, and shipping recipients as parties that may require screening.

The George Washington University

These examples reflect institutional practice and enforcement risk; they should not be mistaken for binding judicial rulings.

Indian Legal Framework

For Indian research institutions, relevant legal controls include:

Foreign Trade (Development and Regulation) Act, 1992: Provides the statutory framework for regulating exports and requiring authorisation.

SCOMET controls: Cover specified dual-use goods, software, technology, and biological materials.

Weapons of Mass Destruction and their Delivery Systems (Prohibition of Unlawful Activities) Act, 2005: Restricts prohibited dealings involving weapons of mass destruction and related materials or technology.

Applicable UN sanctions: Must be observed as implemented through Indian legal instruments.

Screening a partner is not a substitute for determining whether the material or technology itself is controlled. An unsanctioned institution may still be an impermissible end user for a particular controlled item, while a potential name match may require verification rather than immediate rejection.

Practical Compliance Obligations

A sound screening programme should:

Screen research partners, institutions, funders, intermediaries, and relevant end users before entering an agreement.

Verify potential matches using identifying details such as address, registration number, ownership, and affiliated entities.

Classify biological samples, equipment, software, and technical information before transfer.

Confirm end use and final destination, including indirect or onward transfers.

Obtain required licences before export, shipment, or controlled technical disclosure.

Repeat screening when a partner’s status, ownership, location, funding, or project scope changes.

Keep screening records and document the reasoning behind decisions to proceed, pause, or refuse a collaboration.

Screening is only one part of export-control review; controlled information, equipment, or materials may require separate authorisation even where no restricted-party match exists.

Office of Research+1

Conclusion

Sanctions screening in international collaborations helps protect research institutions from prohibited transactions and unauthorised transfers of sensitive biotechnology. The Indiana University settlement demonstrates that academic and scientific activities can attract export-control enforcement when controlled biological materials are shipped without required licences. However, sanctions screening and export licensing are distinct legal requirements.

A compliant institution should conduct partner screening, verify potential matches, assess end use, classify materials and technology, secure necessary authorisations, and maintain ongoing review. These measures support lawful international research while preserving scientific cooperation and public safety.